METL vs. SBIO

Last updated Jun 9, 2026

METL (Sprott Active Metals & Miners ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - METL is a Commodity Producers Equities fund actively managed by Sprott, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. METL is actively managed, while SBIO is passively managed. At a 0.32 correlation, their price movements are largely independent. METL charges 0.89%/yr vs 0.50%/yr for SBIO.

Performance

METL vs. SBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sprott Active Metals & Miners ETF (METL) and ALPS Medical Breakthroughs ETF (SBIO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, METL achieves a 7.51% return, which is significantly higher than SBIO's -1.72% return.

METL

• 1D: 0.05%
• 1M: -9.97%
• YTD: 7.51%
• 6M: 15.84%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SBIO

• 1D: -0.36%
• 1M: -9.33%
• YTD: -1.72%
• 6M: -2.48%
• 1Y: 59.38%
• 3Y*: 16.69%
• 5Y*: 1.33%
• 10Y*: 8.36%

*Multi-year figures are annualized to reflect compound growth (CAGR)

METL vs. SBIO - Yearly Performance Comparison

	2026 (YTD)	2025
METL Sprott Active Metals & Miners ETF	7.51%	28.19%
SBIO ALPS Medical Breakthroughs ETF	-1.72%	39.58%

Correlation

The correlation between METL and SBIO is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Sep 10, 2025	0.32

Return for Risk

METL vs. SBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBIO

SBIO Risk / Return Rank: 73
SBIO Sharpe Ratio Rank: 69
SBIO Sortino Ratio Rank: 70
SBIO Omega Ratio Rank: 60
SBIO Calmar Ratio Rank: 88
SBIO Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

METL vs. SBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sprott Active Metals & Miners ETF (METL) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	METL	SBIO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	2.02	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.04	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.25	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.18	0.21	+0.96

Drawdowns

METL vs. SBIO - Drawdown Comparison

The maximum METL drawdown since its inception was -27.39%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for METL and SBIO.

Drawdown Indicators

	METL	SBIO	Difference
Max Drawdown Largest peak-to-trough decline	-27.39%	-63.06%	+35.67%
Max Drawdown (1Y) Largest decline over 1 year	—	-12.66%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-42.44%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-53.10%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-63.06%	—
Current Drawdown Current decline from peak	-18.48%	-17.90%	-0.58%
Average Drawdown Average peak-to-trough decline	-8.24%	-28.43%	+20.19%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	4.40%	—

Volatility

Volatility by Period

	METL	SBIO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	9.87%	—
Volatility (6M) Calculated over the trailing 6-month period	—	22.68%	—
Volatility (1Y) Calculated over the trailing 1-year period	44.85%	29.62%	+15.23%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.85%	33.56%	+11.29%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	44.85%	33.18%	+11.67%

METL vs. SBIO - Expense Ratio Comparison

METL has a 0.89% expense ratio, which is higher than SBIO's 0.50% expense ratio.

Dividends

METL vs. SBIO - Dividend Comparison

METL's dividend yield for the trailing twelve months is around 0.92%, while SBIO has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
METL Sprott Active Metals & Miners ETF	0.92%	0.99%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SBIO ALPS Medical Breakthroughs ETF	0.00%	0.00%	3.55%	0.22%	0.00%	0.00%	0.00%	0.04%	2.79%	1.77%

Frequently Asked Questions

Can I hold both METL and SBIO in my portfolio?

METL and SBIO have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, METL or SBIO?

On fees, SBIO is cheaper at 0.50% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, METL or SBIO?

SBIO is cheaper with a 0.50% expense ratio, compared with 0.89% for METL.

Which ETF pays a higher dividend yield, METL or SBIO?

METL has the higher dividend yield at 0.92%, compared with 0.00% for SBIO.

What is the main difference between METL and SBIO?

METL is categorized as Commodity Producers Equities, while SBIO is Health & Biotech Equities. They also come from different issuers: Sprott and SS&C. Their fees differ too: 0.89% for METL and 0.50% for SBIO.